Five Prime Therapeutics: 3Q Earnings Snapshot

November 6, 2018

SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Tuesday reported a loss of $47.2 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.37.

The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.17 per share.

The biotech company that develops treatments targeting cancer and autoimmune diseases posted revenue of $5.8 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $7.5 million.

Five Prime Therapeutics shares have decreased 45 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $12.11, a decrease of 72 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FPRX at https://www.zacks.com/ap/FPRX

Update hourly